Implantable Defibrillator User
34
6
10
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
2 terminated out of 34 trials
88.2%
+1.7% vs benchmark
3%
1 trials in Phase 3/4
27%
4 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (34)
TRAjectories and CLinical ExpeRiences of ICD Therapy Study
Effectiveness of Exercise After an ICD
Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)
Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices
Self-Management Interventions After an ICD Shock
Assessment of Combined CCM and ICD Device in HFrEF
Targeted Potassium Levels for Prevention of ICD Therapy
Prognosis Impact of NSVTs After an AMI (TeVeO Study).
Advancing Understanding of Transportation Options
A Personalized and Interactive Web-based Health Care Innovation to Advance the Quality of Care
Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy
Investigation of the Audible ICD Alert Tone
END - VT Cohort Study
Novel ICD Arrhythmia Detection Algorithm
GAMification to Encourage End-Of-Life Discussions Between ICD Patients and Caregivers
Association of Obesity and Cardiovascular Outcomes in Patients With Implantable Cardioverter-defibrillator (ICD)
Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI TRIAL
Shock Testing to Unmask RV Lead and GEnerator Malfunction in ICD Patients: the SURGE-ICD Registry
S-ICD French Cohort Study (HONEST)
Epicardial vs. Transvenous ICDs in Children